Mailton Prestes Madruga, Lucas Kich Grun, Letícya Simone Melo Dos Santos, Frederico Orlando Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, Pedro Luis Silva, Gilson P Dorneles, Paula Coelho Teixeira, Tiago Franco Oliveira, Pedro R T Romão, Lucas Santos, José Claudio Fonseca Moreira, Vinicius Schenk Michaelsen, Marcelo Cypel, Marcos Otávio Brum Antunes, Marcus Herbert Jones, Florencia María Barbé-Tuana, Moisés Evandro Bauer
{"title":"在住院的 COVID-19 患者中,体重超标与 T 细胞衰老加速有关。","authors":"Mailton Prestes Madruga, Lucas Kich Grun, Letícya Simone Melo Dos Santos, Frederico Orlando Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, Pedro Luis Silva, Gilson P Dorneles, Paula Coelho Teixeira, Tiago Franco Oliveira, Pedro R T Romão, Lucas Santos, José Claudio Fonseca Moreira, Vinicius Schenk Michaelsen, Marcelo Cypel, Marcos Otávio Brum Antunes, Marcus Herbert Jones, Florencia María Barbé-Tuana, Moisés Evandro Bauer","doi":"10.1186/s12979-024-00423-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight.</p><p><strong>Results: </strong>Hospitalised COVID-19 patients with overweight and obesity had similarly higher plasma LPS and sCD14 levels than controls (all p < 0.01). Patients with obesity had higher leptin levels than controls. Obesity and overweight patients had similarly higher expansions of classical monocytes and immature natural killer (NK) cells (CD56<sup>+</sup>CD16<sup>-</sup>) than controls. In contrast, reduced proportions of intermediate monocytes, mature NK cells (CD56<sup>+</sup>CD16<sup>+</sup>), and NKT were found in both groups of patients than controls. As expected, COVID-19 patients had a robust expansion of plasmablasts, contrasting to lower proportions of major T-cell subsets (CD4 + and CD8+) than controls. Concerning T-cell activation, overweight and obese patients had lower proportions of CD4<sup>+</sup>CD38<sup>+</sup> cells than controls. Contrasting changes were reported in CD25<sup>+</sup>CD127<sup>low/neg</sup> regulatory T cells, with increased and decreased proportions found in CD4<sup>+</sup> and CD8<sup>+</sup> T cells, respectively. There were similar proportions of T cells expressing checkpoint inhibitors across all groups. We also investigated distinct stages of T-cell differentiation (early, intermediate, and late-differentiated - TEMRA). The intermediate-differentiated CD4 + T cells and TEMRA cells (CD4<sup>+</sup> and CD8<sup>+</sup>) were expanded in patients compared to controls. Senescent T cells can also express NK receptors (NKG2A/D), and patients had a robust expansion of CD8<sup>+</sup>CD57<sup>+</sup>NKG2A<sup>+</sup> cells than controls. Unbiased immune profiling further confirmed the expansions of senescent T cells in COVID-19.</p><p><strong>Conclusions: </strong>These findings suggest that dysregulated immune cells, microbial translocation, and T-cell senescence may partially explain the increased vulnerability to COVID-19 in subjects with excess of body weight.</p>","PeriodicalId":51289,"journal":{"name":"Immunity & Ageing","volume":"21 1","pages":"17"},"PeriodicalIF":5.2000,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921685/pdf/","citationCount":"0","resultStr":"{\"title\":\"Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients.\",\"authors\":\"Mailton Prestes Madruga, Lucas Kich Grun, Letícya Simone Melo Dos Santos, Frederico Orlando Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, Pedro Luis Silva, Gilson P Dorneles, Paula Coelho Teixeira, Tiago Franco Oliveira, Pedro R T Romão, Lucas Santos, José Claudio Fonseca Moreira, Vinicius Schenk Michaelsen, Marcelo Cypel, Marcos Otávio Brum Antunes, Marcus Herbert Jones, Florencia María Barbé-Tuana, Moisés Evandro Bauer\",\"doi\":\"10.1186/s12979-024-00423-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight.</p><p><strong>Results: </strong>Hospitalised COVID-19 patients with overweight and obesity had similarly higher plasma LPS and sCD14 levels than controls (all p < 0.01). Patients with obesity had higher leptin levels than controls. Obesity and overweight patients had similarly higher expansions of classical monocytes and immature natural killer (NK) cells (CD56<sup>+</sup>CD16<sup>-</sup>) than controls. In contrast, reduced proportions of intermediate monocytes, mature NK cells (CD56<sup>+</sup>CD16<sup>+</sup>), and NKT were found in both groups of patients than controls. As expected, COVID-19 patients had a robust expansion of plasmablasts, contrasting to lower proportions of major T-cell subsets (CD4 + and CD8+) than controls. Concerning T-cell activation, overweight and obese patients had lower proportions of CD4<sup>+</sup>CD38<sup>+</sup> cells than controls. Contrasting changes were reported in CD25<sup>+</sup>CD127<sup>low/neg</sup> regulatory T cells, with increased and decreased proportions found in CD4<sup>+</sup> and CD8<sup>+</sup> T cells, respectively. There were similar proportions of T cells expressing checkpoint inhibitors across all groups. We also investigated distinct stages of T-cell differentiation (early, intermediate, and late-differentiated - TEMRA). The intermediate-differentiated CD4 + T cells and TEMRA cells (CD4<sup>+</sup> and CD8<sup>+</sup>) were expanded in patients compared to controls. Senescent T cells can also express NK receptors (NKG2A/D), and patients had a robust expansion of CD8<sup>+</sup>CD57<sup>+</sup>NKG2A<sup>+</sup> cells than controls. Unbiased immune profiling further confirmed the expansions of senescent T cells in COVID-19.</p><p><strong>Conclusions: </strong>These findings suggest that dysregulated immune cells, microbial translocation, and T-cell senescence may partially explain the increased vulnerability to COVID-19 in subjects with excess of body weight.</p>\",\"PeriodicalId\":51289,\"journal\":{\"name\":\"Immunity & Ageing\",\"volume\":\"21 1\",\"pages\":\"17\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-03-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921685/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunity & Ageing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12979-024-00423-6\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity & Ageing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12979-024-00423-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:冠状病毒病-19(COVID-19)的临床进展不佳与多种风险因素有关,其中包括衰老和肥胖。SARS-CoV-2可能会通过细胞损伤和旁分泌性炎症损害肺功能;而肥胖与过早的免疫衰老、微生物易位和先天性免疫反应失调有关,从而导致对一系列病毒和细菌感染的免疫反应低下。在此,我们对不同体重的 COVID-19 住院患者的免疫衰老、微生物易位和免疫失调进行了全面描述:结果:超重和肥胖的 COVID-19 住院患者的血浆 LPS 和 sCD14 水平同样高于对照组(均为 p +CD16-)。相比之下,两组患者的中间单核细胞、成熟 NK 细胞(CD56+CD16+)和 NKT 的比例均低于对照组。正如预期的那样,COVID-19 患者的浆细胞大量扩增,而主要 T 细胞亚群(CD4 + 和 CD8+)的比例则低于对照组。在 T 细胞活化方面,超重和肥胖患者的 CD4+CD38+ 细胞比例低于对照组。CD25+CD127-low/neg调节性T细胞发生了相反的变化,CD4+和CD8+T细胞的比例分别增加和减少。所有组中表达检查点抑制剂的 T 细胞比例相似。我们还研究了T细胞分化的不同阶段(早期分化、中期分化和晚期分化--TEMRA)。与对照组相比,患者体内中度分化的 CD4 + T 细胞和 TEMRA 细胞(CD4 + 和 CD8 +)增大。衰老的T细胞也能表达NK受体(NKG2A/D),与对照组相比,患者的CD8+CD57+NKG2A+细胞扩增明显。无偏见的免疫分析进一步证实了COVID-19中衰老T细胞的扩增:这些研究结果表明,免疫细胞失调、微生物易位和T细胞衰老可能是体重超标患者更易感染COVID-19的部分原因。
Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients.
Background: Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight.
Results: Hospitalised COVID-19 patients with overweight and obesity had similarly higher plasma LPS and sCD14 levels than controls (all p < 0.01). Patients with obesity had higher leptin levels than controls. Obesity and overweight patients had similarly higher expansions of classical monocytes and immature natural killer (NK) cells (CD56+CD16-) than controls. In contrast, reduced proportions of intermediate monocytes, mature NK cells (CD56+CD16+), and NKT were found in both groups of patients than controls. As expected, COVID-19 patients had a robust expansion of plasmablasts, contrasting to lower proportions of major T-cell subsets (CD4 + and CD8+) than controls. Concerning T-cell activation, overweight and obese patients had lower proportions of CD4+CD38+ cells than controls. Contrasting changes were reported in CD25+CD127low/neg regulatory T cells, with increased and decreased proportions found in CD4+ and CD8+ T cells, respectively. There were similar proportions of T cells expressing checkpoint inhibitors across all groups. We also investigated distinct stages of T-cell differentiation (early, intermediate, and late-differentiated - TEMRA). The intermediate-differentiated CD4 + T cells and TEMRA cells (CD4+ and CD8+) were expanded in patients compared to controls. Senescent T cells can also express NK receptors (NKG2A/D), and patients had a robust expansion of CD8+CD57+NKG2A+ cells than controls. Unbiased immune profiling further confirmed the expansions of senescent T cells in COVID-19.
Conclusions: These findings suggest that dysregulated immune cells, microbial translocation, and T-cell senescence may partially explain the increased vulnerability to COVID-19 in subjects with excess of body weight.
期刊介绍:
Immunity & Ageing is a specialist open access journal that was first published in 2004. The journal focuses on the impact of ageing on immune systems, the influence of aged immune systems on organismal well-being and longevity, age-associated diseases with immune etiology, and potential immune interventions to increase health span. All articles published in Immunity & Ageing are indexed in the following databases: Biological Abstracts, BIOSIS, CAS, Citebase, DOAJ, Embase, Google Scholar, Journal Citation Reports/Science Edition, OAIster, PubMed, PubMed Central, Science Citation Index Expanded, SCImago, Scopus, SOCOLAR, and Zetoc.